Supporting clinical teams

The latest vascular access & infusion therapy evidence, made easy for clinical teams.

IVTEAM is a global resource bringing healthcare professionals daily updates on the most relevant vascular access and infusion therapy evidence — free to read, wherever you work.

Pain reduction during intravenous cannulation

“Pain intensity declined substantially over time in all groups. In the primary analysis, Diclofenac and EMLA were associated with lower early pain intensity than Piroxicam, although some pairwise findings were sensitive to the analytical approach” Amini et al (2026).

Read More »

Severe consequence of unnecessary retention of a TIVAD

“Leaving an inactive device for 12 months post-treatment represents a significant risk. Furthermore, a false-negative initial ultrasound led to a critical diagnostic delay, underscoring that strong clinical suspicion should sometimes override early negative imaging to prevent progression from deep vein thrombosis to PCD” Delorme et al (2026).

Read More »

Chlorhexidine gluconate significantly reduces CLABSI

“CHG intervention can significantly reduce the risk of CLABSI, and the protective effect varies by intervention type: catheter coating/impregnation interventions have the strongest protective effect, dressing interventions have a moderate protective effect, while daily bathing showed no significant effect” Zhang et al (2026).

Read More »

OPAT in infants aged under 1 year

“Our findings suggest OPAT decisions for infants aged under 1 year should also incorporate factors such as duration of therapy and underlying conditions, rather than age alone, to help reduce the risk of OPAT” Beauchamp-Walters et al (2026).

Read More »

Pediatric contrast media administration

“This study surveyed CT radiographers about their knowledge of contrast dye use in children and the practices they use in clinical care. This study found that many radiographers lacked knowledge in important safety and dosing areas, even though most felt confident about making changes to contrast protocols” Rawashdeh et al (2026).

Read More »